The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Clinical presentation, diagnosis and long-term outcome of Wilson’s disease: a cohort study
Open accessAbstract
Background: Wilson’s disease is a rare inborn disease related to copper storage, leading to liver cirrhosis and neuropsychological deterioration. Clinical data on larger cohorts are limited owing to low disease frequency. Objective and methods: We performed a retrospective analysis of 163 patients with Wilson’s disease, examined at the University of Heidelberg, Heidelberg, Germany, to determine clinical presentation, diagnostic course and long-term outcome. Results: Diagnostic criteria for non-caeruloplasmin-bound serum copper, serum caeruloplasmin, 24-h urinary copper excretion, liver copper content, presence of Kayser–Fleischer rings and histological signs of chronic liver damage were reached in 86.6%, 88.2%, 87.1%, 92.7%, 66.3% and 73% of patients, respectively. By analysis of the coding region of ATP7B (except exons 2, 3 and 21), disease-causing mutations were detected in 57% and 29% of patients with Wilson’s disease on both chromosomes and on one chromosome, respectively. No mutations were detected in 15% of patients with Wilson’s disease. No significant differences were found in clinical parameters or initial presentation between patients grouped according to their mutations. The patients with neurological symptoms were significantly older at the onset of symptoms than patients with hepatitic symptoms (20.2 v 15.5 years of age, p<0.05), and the neurological symptoms were associated with a significantly longer time from onset to diagnosis than hepatic symptoms (44.4 v 14.4 months, p<0.05). After initiating treatment, 76.1% of the patients had a stable or improved course of the disease. Disease progression under treatment was more likely for neuropsychiatric than for hepatic symptoms. Side effects of treatment occurred in 74.4% of patients. Conclusions: Patients with Wilson’s disease having predominantly neuropsychiatric symptoms manifest symptoms later, have a longer time delay from onset of symptoms until definitive diagnosis and have a poorer outcome than patients with hepatic symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Wilson disease gene is a putative copper transporting P–type ATPase similar to the Menkes gene
Bull, P. C., Thomas, G. R., Rommens, J. M., Forbes, J. R., & Cox, D. W. (1993) · Nature Genetics · doi:10.1038/ng1293-327 · Cited by 1,948
The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene
Tanzi, R. E., Petrukhin, K., Chernov, I., Pellequer, J. L., Wasco, W., Ross, B., Romano, D. M., Parano, E., Pavone, L., Brzustowicz, L. M., et al. (1993) · Nature Genetics · doi:10.1038/ng1293-344 · Cited by 1,375
Diagnosis and phenotypic classification of Wilson disease1
Ferenci, P., Caca, K., Loudianos, G., Mieli‐Vergani, G., Tanner, S., Sternlieb, I., Schilsky, M., Cox, D., & Berr, F. (2003) · Liver International · doi:10.1034/j.1600-0676.2003.00824.x · Cited by 927
Self-citationThe Wilson disease gene: spectrum of mutations and their consequences
Thomas, G. R., Forbes, J. R., Roberts, E. A., Walshe, J. M., & Cox, D. W. (1995) · Nature Genetics · doi:10.1038/ng0295-210 · Cited by 568
A Practice Guideline on Wilson Disease
Roberts, E. A., & Schilsky, M. L. (2003) · Hepatology · doi:10.1053/jhep.2003.50252 · Cited by 452
Shah, A. B., Chernov, I., Zhang, H. T., Ross, B. M., Das, K., Lutsenko, S., Parano, E., Pavone, L., Evgrafov, O., Ivanova-Smolenskaya, I. A., et al. (1997) · The American Journal of Human Genetics · doi:10.1086/514864 · Cited by 348
Gitlin, J. D. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.05.010 · Cited by 343
Wilson Disease: Clinical Presentation, Treatment, and Survival
Stremmel, W., Meyerrose, K.-W., Niederau, C., Hefter, H., Kreuzpaintner, G., & Strohmeyer, G. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-9-720 · Cited by 303
Self-citationScheinberg, I. H. (1981) · PubMed · Cited by 257
Huster, D., Finegold, M. J., Morgan, C. T., Burkhead, J. L., Nixon, R., Vanderwerf, S. M., Gilliam, C. T., & Lutsenko, S. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050312 · Cited by 224
Recognition, Diagnosis, and Management of Wilson's Disease
Brewer, G. J. (2000) · Proceedings of the Society for Experimental Biology and Medicine · doi:10.1046/j.1525-1373.2000.22305.x · Cited by 192
Management of Wilson's disease with zinc sulphate
Hoogenraad, T. U., Van Hattum, J., & Van den Hamer, C. J. A. (1987) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(87)90116-x · Cited by 185
Et, C., & Costa Ade, L. (1965) · PubMed · Cited by 177
Caca, K., Ferenci, P., Kühn, H.-J., Polli, C., Willgerodt, H., Kunath, B., Hermann, W., Mössner, J., & Berr, F. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00219-7 · Cited by 164
Self-citationSchiefermeier, M., Kollegger, H., Madl, C., Polli, C., Oder, W., Kühn, H., Berr, F., & Ferenci, P. (2000) · Brain · doi:10.1093/brain/123.3.585 · Cited by 154
Self-citationTreatment of Wilson's disease with zinc
Brewer, G. J. (1999) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(99)90213-5 · Cited by 153
Askari, F. K., Greenson, J. K., Dick, R. D., Johnson, V. R., & Brewer, G. J. (2003) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(03)00157-4 · Cited by 128
Practical recommendations and new therapies for Wilson's disease
Brewer, G. J. (1995) · Drugs · doi:10.2165/00003495-199550020-00004 · Cited by 92
Common mutations of ATP7B in Wilson disease patients from Hungary
Firneisz, G., Lakatos, P. L., Szalay, F., Polli, C., Glant, T. T., & Ferenci, P. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10220 · Cited by 88
Self-citationClinical correlation of brain MRI and MRS abnormalities in patients with Wilson disease
Page, R., Davie, C. A., MacManus, D. G., Miszkiel, K., Walshe, J. M., Miller, D., Lees, A. J., & Schapira, A. H. V. (2004) · Neurology · doi:10.1212/01.wnl.0000134793.50831.c1 · Cited by 65
Treatment of Wilson's disease with zinc: XIV studies of the effect of zinc on lymphocyte function
Brewer, G. J., Johnson, V. R., & Kaplan, J. (1997) · Journal of Laboratory and Clinical Medicine · doi:10.1016/s0022-2143(97)90200-6 · Cited by 35
Cited by
Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S., & Schilsky, M. L. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60196-2 · Cited by 1,446
Diagnosis and treatment of Wilson disease: An update
Roberts, E. A., & Schilsky, M. L. (2008) · Hepatology · doi:10.1002/hep.22261 · Cited by 1,299
EASL Clinical Practice Guidelines: Wilson’s disease
European Association for the Study of the Liver (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2011.11.007 · Cited by 1,243
Global Epidemiology and Genetics of Hepatocellular Carcinoma
Toh, M. R., Wong, E. Y. T., Wong, S. H., Ng, A. W. T., Loo, L.-H., Chow, P. K.-H., & Ngeow, J. (2023) · Gastroenterology · doi:10.1053/j.gastro.2023.01.033 · Cited by 583
Lorincz, M. T. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05109.x · Cited by 370
Metadata
- Authors
- Merle, U., Schaefer, M., Ferenci, P., & Stremmel, W.
- Venue
- Gut
- Publisher
- BMJ
- Published
- 2006-05-18
- Volume
- 56
- Issue
- 1
- Pages
- 115-120
- ISSN
- 0017-5749 (ISSN-L)
- 1468-3288
- OpenAlex
- W2141060691
- Cited by
- 625
- References
- 21
- FWCI
- 12.53
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.